115 related articles for article (PubMed ID: 19718945)
21. Effect of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea on experimental tumors.
Hisamatsu T; Uchida S
Gan; 1977 Dec; 68(6):819-24. PubMed ID: 202535
[TBL] [Abstract][Full Text] [Related]
22. Biologic activity of MCNU: a new antitumor agent.
Sekido S; Ninomiya K; Iwasaki M
Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
[TBL] [Abstract][Full Text] [Related]
23. Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars.
Roger P; Monneret C; Fournier JP; Choay P; Gagnet R; Gosse C; Letourneux Y; Atassi G; Gouyette A
J Med Chem; 1989 Jan; 32(1):16-23. PubMed ID: 2909727
[TBL] [Abstract][Full Text] [Related]
24. Evaluation of 2-(methylaminosulfonyl)-1-(arylsulfonyl)hydrazines as anticancer agents.
Ghosh M; Dutta S; Sanyal U
Neoplasma; 1999; 46(4):242-5. PubMed ID: 10613605
[TBL] [Abstract][Full Text] [Related]
25. In vivo anti-tumour activity of novel Quinazoline derivatives.
Alapati V; Noolvi MN; Manjula SN; Pallavi KJ; Patel HM; Tippeswamy BS; Satyanarayana SV
Eur Rev Med Pharmacol Sci; 2012 Nov; 16(13):1753-64. PubMed ID: 23208959
[TBL] [Abstract][Full Text] [Related]
26. Novel mononuclear ruthenium(II) compounds in cancer therapy.
Anchuri SS; Thota S; Yerra R; Devarakonda KP; Dhulipala S
Asian Pac J Cancer Prev; 2012; 13(7):3293-8. PubMed ID: 22994750
[TBL] [Abstract][Full Text] [Related]
27. Development of differential cytotoxic compounds containing nitrosourea and benzothiazine nucleus.
Nyati MK; Rai D; Gupta RR; Dev PK
In Vivo; 1997; 11(1):95-9. PubMed ID: 9067778
[TBL] [Abstract][Full Text] [Related]
28. Antitumour activity of saffron (Crocus sativus).
Nair SC; Pannikar B; Panikkar KR
Cancer Lett; 1991 May; 57(2):109-14. PubMed ID: 2025883
[TBL] [Abstract][Full Text] [Related]
29. Preliminary evaluation of in vitro cytotoxicity and in vivo antitumor activity of Premna herbacea Roxb. in Ehrlich ascites carcinoma model and Dalton's lymphoma ascites model.
Dhamija I; Kumar N; Manjula SN; Parihar V; Setty MM; Pai KS
Exp Toxicol Pathol; 2013 Mar; 65(3):235-42. PubMed ID: 21920724
[TBL] [Abstract][Full Text] [Related]
30. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
[TBL] [Abstract][Full Text] [Related]
31. 4-aryl/heteroaryl-4H-fused Pyrans as Anti-proliferative Agents: Design, Synthesis and Biological Evaluation.
Kumar D; Singh G; Sharma P; Qayum A; Mahajan G; Mintoo MJ; Singh SK; Mondhe DM; Bedi PMS; Jain SK; Gupta GK
Anticancer Agents Med Chem; 2018; 18(1):57-73. PubMed ID: 28925877
[TBL] [Abstract][Full Text] [Related]
32. Spirogermanium: a new investigational drug of novel structure and lack of bone marrow toxicity.
Slavik M; Blanc O; Davis J
Invest New Drugs; 1983; 1(3):225-34. PubMed ID: 6678870
[TBL] [Abstract][Full Text] [Related]
33. Antitumor efficacy and amelioration of oxidative stress by Trichosanthes dioica root against Ehrlich ascites carcinoma in mice.
Bhattacharya S; Prasanna A; Majumdar P; Kumar RB; Haldar PK
Pharm Biol; 2011 Sep; 49(9):927-35. PubMed ID: 21819262
[TBL] [Abstract][Full Text] [Related]
34. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities.
Eisenbrand G
IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062
[TBL] [Abstract][Full Text] [Related]
35. Comparison of antitumor activities of nitrosourea derivatives against mammary breast carcinoma (MX-1) in nude mice.
Inoue K; Fujimoto S; Ogawa M
Gan; 1980 Oct; 71(5):686-91. PubMed ID: 7227717
[TBL] [Abstract][Full Text] [Related]
36. Antitumor activity and toxicity of ACNU, 3-[(4-amino-2-methyl-5-pyrimidinyl)methyl]-1-(2-chloroethyl)-1-nitroso urea hydrochloride, comparing two divided doses and a single dose.
Fujimoto S; Wang Y; Ogawa M
Cancer Chemother Pharmacol; 1984; 12(3):173-8. PubMed ID: 6584235
[TBL] [Abstract][Full Text] [Related]
37. A new class of antimetabolites: pyridine thioglycosides as potential anticancer agents.
Elgemeie GH; Mahdy EM; Elgawish MA; Ahmed MM; Shousha WG; Eldin ME
Z Naturforsch C J Biosci; 2010; 65(9-10):577-87. PubMed ID: 21138059
[TBL] [Abstract][Full Text] [Related]
38. Activity of fotemustine in medulloblastoma and malignant glioma xenografts in relation to O6-alkylguanine-DNA alkyltransferase and alkylpurine-DNA N-glycosylase activity.
Vassal G; Boland I; Terrier-Lacombe MJ; Watson AJ; Margison GP; Vénuat AM; Morizet J; Parker F; Lacroix C; Lellouch-Tubiana A; Pierre-Kahn A; Poullain MG; Gouyette A
Clin Cancer Res; 1998 Feb; 4(2):463-8. PubMed ID: 9516937
[TBL] [Abstract][Full Text] [Related]
39. Synthesis and evaluation of substituted naphthalimide nitrogen mustards as rationally designed anticancer compounds.
Pain A; Samanta S; Dutta S; Saxena AK; Shanmugavel M; Kampasi H; Quazi GN; Sanyal U
Acta Pol Pharm; 2003; 60(4):285-91. PubMed ID: 14714857
[TBL] [Abstract][Full Text] [Related]
40. Anti-tumour, toxicological and pharmacokinetic properties of a novel taurine-based nitrosourea (TCNU).
Hartley-Asp B; Christensson PI; Gunnarsson K; Gunnarsson PO; Jensen G; Polacek J; Stamvik A
Invest New Drugs; 1988 Apr; 6(1):19-30. PubMed ID: 3410663
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
